News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,850 Results
Type
Article (87746)
Company Profile (824)
Press Release (778263)
Multimedia
Podcasts (186)
Webinars (28)
Section
Business (233166)
Career Advice (4143)
Deals (39830)
Drug Delivery (144)
Drug Development (91354)
Employer Resources (203)
FDA (18353)
Job Trends (17414)
News (397696)
Policy (39947)
Tag
Academia (3006)
Academic (2)
Accelerated approval (25)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (170)
Alzheimer's disease (1759)
Antibody-drug conjugate (ADC) (302)
Approvals (18455)
Artificial intelligence (578)
Autoimmune disease (131)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (188)
Biotechnology (488)
Bladder cancer (150)
Brain cancer (61)
Breast cancer (613)
Cancer (4663)
Cardiovascular disease (406)
Career advice (3565)
Career pathing (40)
CAR-T (289)
CDC (59)
Celiac Disease (1)
Cell therapy (783)
Cervical cancer (36)
Clinical research (76516)
Collaboration (1586)
Company closure (5)
Compensation (1063)
Complete response letters (65)
COVID-19 (2976)
CRISPR (93)
C-suite (735)
Cystic fibrosis (147)
Data (5804)
Decentralized trials (2)
Denatured (68)
Depression (132)
Diabetes (492)
Diagnostics (7165)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (270)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (224)
Earnings (99885)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134492)
Executive appointments (1009)
FDA (21192)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1429)
Gene editing (201)
Generative AI (60)
Gene therapy (620)
GLP-1 (1082)
Government (5418)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (45)
IgA nephropathy (80)
Immunology and inflammation (275)
Immuno-oncology (39)
Indications (76)
Infectious disease (3245)
Inflammatory bowel disease (197)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (217)
Interviews (816)
IPO (17942)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (652)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (646)
Lymphoma (358)
Machine learning (40)
Management (66)
Manufacturing (741)
MASH (164)
Medical device (14967)
Medtech (15006)
Mergers & acquisitions (22869)
Metabolic disorders (1286)
Multiple sclerosis (150)
NASH (23)
Neurodegenerative disease (322)
Neuropsychiatric disorders (86)
Neuroscience (2953)
NextGen: Class of 2025 (7703)
Non-profit (5102)
Now hiring (61)
Obesity (618)
Opinion (326)
Ovarian cancer (153)
Pain (186)
Pancreatic cancer (198)
Parkinson's disease (272)
Partnered (34)
Patents (468)
Patient recruitment (401)
Peanut (58)
People (66622)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23624)
Phase II (33212)
Phase III (25034)
Pipeline (3829)
Policy (318)
Postmarket research (3554)
Preclinical (10663)
Press Release (72)
Prostate cancer (227)
Psychedelics (52)
Radiopharmaceuticals (285)
Rare diseases (802)
Real estate (7436)
Recruiting (80)
Regulatory (28534)
Reports (65)
Research institute (2715)
Resumes & cover letters (651)
Rett syndrome (24)
RNA editing (16)
RSV (82)
Schizophrenia (148)
Series A (234)
Series B (177)
Service/supplier (30)
Sickle cell disease (100)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4325)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (116)
Vaccines (1102)
Venture capital (76)
Weight loss (433)
Women's health (77)
Worklife (21)
Date
Today (63)
Last 7 days (615)
Last 30 days (2494)
Last 365 days (33296)
2025 (32386)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (325)
Arkansas (14)
Asia (51306)
Australia (9015)
California (10782)
Canada (3165)
China (1048)
Colorado (453)
Connecticut (479)
Delaware (322)
Europe (117952)
Florida (1578)
Georgia (348)
Hawaii (3)
Idaho (68)
Illinois (889)
India (62)
Indiana (519)
Iowa (22)
Japan (374)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1395)
Massachusetts (7987)
Michigan (340)
Minnesota (625)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (117)
New Hampshire (81)
New Jersey (2943)
New Mexico (32)
New York (2885)
North Carolina (1531)
North Dakota (10)
Northern California (5078)
Ohio (327)
Oklahoma (22)
Oregon (52)
Pennsylvania (2186)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4140)
Tennessee (166)
Texas (1696)
United States (39228)
Utah (323)
Vermont (1)
Virginia (270)
Washington D.C. (85)
Washington State (911)
West Virginia (4)
Wisconsin (112)
Wyoming (2)
866,850 Results for "'".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amphastar Announces FDA Approval for Teriparatide Injection
December 15, 2025
·
6 min read
Press Releases
Palvella Therapeutics Announces Positive Topline Results from Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Cutaneous Venous Malformations, a Serious, Rare Genetic Disease with No FDA-approved Therapies
December 15, 2025
·
13 min read
Press Releases
Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01
December 15, 2025
·
9 min read
Press Releases
Patient Enrolment Completed in Phase 2 aGvHD Clinical Trial
December 15, 2025
·
4 min read
Press Releases
Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis
December 15, 2025
·
8 min read
Press Releases
Proton Therapy New Standard of Care for Patients with Oropharyngeal Cancer
December 15, 2025
·
3 min read
Press Releases
Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
December 15, 2025
·
5 min read
Press Releases
argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
December 15, 2025
·
6 min read
Press Releases
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
December 15, 2025
·
4 min read
Press Releases
Viva Biotech’s invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.
December 15, 2025
·
5 min read
1 of 86,685
Next
